Akebia Therapeutics Inc (AKBA.OQ)
AKBA.OQ on NASDAQ Stock Exchange Global Market
5.26USD
23 May 2019
5.26USD
23 May 2019
Change (% chg)
$-0.31 (-5.57%)
$-0.31 (-5.57%)
Prev Close
$5.57
$5.57
Open
$5.51
$5.51
Day's High
$5.54
$5.54
Day's Low
$5.18
$5.18
Volume
360,636
360,636
Avg. Vol
313,596
313,596
52-wk High
$11.60
$11.60
52-wk Low
$5.18
$5.18
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- ownership
- filings
- deals
- private equity
- third-party document and information retrieval
- estimates
- fundamentals
- economics
- events
- news
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
| Name | Age | Since | Current Position |
|---|---|---|---|
John Butler |
53 | 2013 | President, Chief Executive Officer, Director |
Jason Amello |
49 | 2013 | Chief Financial Officer, Senior Vice President, Treasurer |
Nicole Hadas |
45 | 2013 | Senior Vice President, General Counsel, Secretary |
Michel Dahan |
39 | 2013 | Senior Vice President and Chief Business Officer |
Dell Faulkingham |
2019 | Senior Vice President, Chief Commercial Officer |